Clinical Trial Update: CPAx: Responsiveness and Minimal Clinically Important Difference

View source ↗

Summary

Clinical trial update for CPAx assessing responsiveness and minimal clinically important difference in conditions including muscle weakness and critical illness…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Illness Myopathy
• Critical Illness Polyneuromyopathy
• Critical Illness Polyneuropathy
• Muscle Weakness

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Muscle Weakness, Critical Illness Myopathy | Status: RECRUITING